Literature DB >> 7882321

Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens.

S Yamamoto1, Y Konishi, T Matsuda, T Murai, M A Shibata, I Matsui-Yuasa, S Otani, K Kuroda, G Endo, S Fukushima.   

Abstract

Arsenic (As) is environmentally ubiquitous and an epidemiologically significant chemical related to certain human cancers. Dimethylarsinic acid (cacodylic acid; DMA) is one of the major methylated metabolites of ingested arsenicals in most mammals. To evaluate the effects of DMA on chemical carcinogenesis, we conducted a multiorgan bioassay in rats given various doses of DMA. One-hundred twenty-four male F344/DuCrj rats were divided randomly into 7 groups (20 rats each for groups 1-5; 12 rats each for groups 6 and 7). To initiate multiple organs and tissues, animals in groups 1-5 were treated sequentially with diethylnitrosamine (100 mg/kg body weight, i.p., single dose at the commencement) and N-methyl-N-nitrosourea (20 mg/kg body weight, i.p., 4 times, on days 5, 8, 11, and 14). Thereafter, rats received 1,2-dimethylhydrazine (40 mg/kg body weight, s.c., 4 times, on days 18, 22, 26, and 30). During the same period, the animals were sequentially administered N-butyl-N-(4-hydroxybutyl)nitrosamine (0.05% in the drinking water, during weeks 1 and 2) and N-bis(2-hydroxypropyl)nitrosamine (0.1% in the drinking water, during weeks 3 and 4; DMBDD treatment). After a 2-week interval, groups 2-5 were given 50, 100, 200, or 400 ppm DMA, respectively, in the drinking water. Groups 6 and 7, which were not given DMBDD treatment, received 100 and 400 ppm DMA during weeks 6-30. All rats were killed at the end of week 30. In the initiated groups (groups 1-5), DMA significantly enhanced the tumor induction in the urinary bladder, kidney, liver, and thyroid gland, with respective incidences in group 5 (400 ppm DMA) being 80, 65, 65, and 45%. Induction of preneoplastic lesions (glutathione S-transferase placental form-positive foci in the liver and atypical tubules in the kidney) was also significantly increased in DMA-treated groups. Ornithine decarboxylase activity in the kidneys of rats treated with 100 ppm DMA was significantly increased compared with control values (P < 0.001). In conclusion, DMA is acting as a promoter of urinary bladder, kidney, liver, and thyroid gland carcinogenesis in rats, and we speculate that this may be related to cancer induction by As in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882321

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

Review 1.  Heavy metal, polychlorinated biphenyl and organochlorine pesticide residues in marine organisms: risk evaluation for consumers.

Authors:  G O Marcotrigiano; M M Storelli
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite.

Authors:  Vicenta Devesa; Blakely M Adair; Jie Liu; Michael P Waalkes; Bhalchandra A Diwan; Miroslav Styblo; David J Thomas
Journal:  Toxicology       Date:  2006-05-03       Impact factor: 4.221

3.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

4.  Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage.

Authors:  Wei Ding; Wenlan Liu; Karen L Cooper; Xu-Jun Qin; Patrícia L de Souza Bergo; Laurie G Hudson; Ke Jian Liu
Journal:  J Biol Chem       Date:  2008-12-03       Impact factor: 5.157

Review 5.  Molecular Mechanisms of Arsenic-Induced Disruption of DNA Repair.

Authors:  Lok Ming Tam; Nathan E Price; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2020-02-07       Impact factor: 3.739

6.  Arsenic exposure in utero and nonepidermal proliferative response in adulthood in Tg.AC mice.

Authors:  Erik J Tokar; Bhalchandra A Diwan; Michael P Waalkes
Journal:  Int J Toxicol       Date:  2010 May-Jun       Impact factor: 2.032

Review 7.  Arsenic carcinogenicity: relevance of c-Src activation.

Authors:  Petia P Simeonova; Michael I Luster
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 8.  Liver is a target of arsenic carcinogenesis.

Authors:  Jie Liu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2008-06-19       Impact factor: 4.849

9.  Reduction of arsenite-enhanced ultraviolet radiation-induced DNA damage by supplemental zinc.

Authors:  Karen L Cooper; Brenee S King; Monica M Sandoval; Ke Jian Liu; Laurie G Hudson
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-21       Impact factor: 4.219

10.  Genetic integrity of the human Y chromosome exposed to groundwater arsenic.

Authors:  Safdar Ali; Sher Ali
Journal:  BMC Med Genomics       Date:  2010-08-06       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.